510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K924006Substantially Equivalent

Bartel Prima System Influenza a Enzyme Immunoassay

Baxter Healthcare Corporation, Issauah WA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K924006 is the FDA 510(k) clearance record for BARTEL PRIMA SYSTEM INFLUENZA A ENZYME IMMUNOASSAY, a class I device, cleared for Baxter Healthcare Corp on under FDA product code GNX (Antigens, Cf (Including Cf Control), Influenza Virus A, B, C). FDA records list 570 510(k) clearances for Baxter Healthcare Corp, from to . As of , FDA records show no recalls naming K924006.

Clearance record

Decision date
Received
(141 days to decision)
Product code
GNX Antigens, Cf (Including Cf Control), Influenza Virus A, B, C
Regulation
21 CFR 866.3330
Device class
Class I
Review panel
Microbiology
Applicant
Baxter Healthcare Corp 2005 NW Sammamish Rd., Issauah WA
510(k) summary
Summary
Third party review
No

Clearances, product code GNX

Trailing 12 months

FDA records hold no clearances under product code GNX in the trailing twelve months.

FDA records show no clearances under product code GNX in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code GNX, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260